FindTrial
Sign In

Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients

Novel Coronavirus infection in myocardial injury and its prognosis: a multi-center, long-term follow-up, registry study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029865
Enrollment
Unknown
Registered
2020-02-15
Start date
2020-02-20
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

common group:N/A
severe group:N/A
critical group:N/A

Sponsors

Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who were diagnosed as COVID-19 according to the interim guidance of China National Health Commission (NHC) were screened in this study. CVD included hypertension, coronary heart disease or/and heart failure confirmedly diagnosed in the past.

Exclusion criteria

Exclusion criteria: 1. Aged <18 years; 2. Patients with systemic disease and severe liver and kidney dysfunction were excluded.

Design outcomes

Primary

MeasureTime frame
blood cell count;C-reactive protein (CRP);arterial blood-gas analysis;markers of myocardial injury;coagulation profile;serum biochemical test;brain natriuretic peptide(BNP);blood lipid;fibrinogen(FIB), D-Dimer.;—

Countries

China

Contacts

Public ContactPeng Yudong, Huang Kai

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

am-penicillin@163.com+86 13886157176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026